S&P 500
(0.03%) 5 470.99 points
Dow Jones
(0.04%) 39 129 points
Nasdaq
(0.32%) 17 774 points
Oil
(-0.24%) $80.64
Gas
(-5.04%) $2.62
Gold
(-0.91%) $2 309.60
Silver
(-0.39%) $28.76
Platinum
(3.07%) $1 016.70
USD/EUR
(0.35%) $0.936
USD/NOK
(0.74%) $10.68
USD/GBP
(0.52%) $0.792
USD/RUB
(-0.28%) $87.25

Sanntidsoppdatering for Homology Medicines Inc [FIXX]

Børs: NASDAQ Sektor: Healthcare Industri: Biotechnology
Sist oppdatert25 mar 2024 @ 21:00

0.77% $ 0.935

Live Chart Being Loaded With Signals

Commentary (25 mar 2024 @ 21:00):
Our systems believe the stock currently is undervalued by 1 671.69% compare to its pairs and should correct upwards.
Profile picture for Homology Medicines Inc

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders...

Stats
Dagens volum 401 467
Gjennomsnittsvolum 29 535
Markedsverdi 3.02M
EPS $1.030 ( Q1 | 2024-05-09 )
Neste inntjeningsdato ( $0 ) 2024-08-12
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.0266
(Sector) 42.63
(Industry) 24.32
ATR14 $0.122 (0.74%)
AADI -6.18%
ABCL 0.92%
ABCM 0.04%
ABEO -3.31%
ABIO -0.30%
ABOS 3.74%
ABSI 2.89%
ABUS -1.15%
ABVX -3.00%
ACAD -0.45%
ACER -17.95%
ACET -8.95%
ACGN 1.29%
ACHL -1.70%
ACHV 2.27%
ACIU -0.75%
ACLX -0.69%
ACRV -4.63%
ACST -3.58%
ACXP 3.69%
ADAG 7.14%
ADAP -3.98%
ADGI 0.87%
ADIL -3.68%
ADMA -1.23%
ADPT 0.44%
ADTX -3.47%
ADVM 1.45%
ADXN -1.60%
AEON -4.67%
AEZS -2.49%
AFMD -2.97%
AGEN -4.04%
AGIO -2.60%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA 8.16%
AKRO -2.68%
AKTX -5.23%
AKUS 0.00%
ALBO 0.00%
ALDX -2.40%
ALEC -1.03%
ALGS -3.03%
ALKS 1.94%
ALLK -11.39%
ALLO -2.92%
ALLR -1.63%
ALNA 3.16%
ALNY 2.37%
ALPN 0.02%
ALPX 0.00%
ALRN -1.67%
ALT -15.52%
ALVR -0.53%
ALXN 0.00%
ALXO -9.74%
ALZN 5.10%
AMRN -3.75%
AMTI -3.13%
ANAB 1.51%
ANEB 7.95%
ANGN 0.00%
ANIX -3.64%
ANL -0.14%
ANNX 3.93%
ANPC -3.15%
APGE 1.16%
APGN 8.48%
APGNW 30.65%
APLM -5.86%
APLS 0.31%
APLT 0.67%
APM 1.47%
APOP 0.38%
APRE -3.13%
APTO 0.62%
APTX 3.17%
APVO 0.38%
ARAV -13.39%
ARCT -6.47%
ARDS -12.13%
ARDX 2.16%
ARGX -0.63%
ARNA 0.00%
ARPO -0.90%
ARQT -3.07%
ARTL -2.50%
ARTLW 0.00%
ARVN 6.93%
ARWR -2.57%
ASLN -4.68%
ASMB -5.55%
ASND -1.80%
ATAI -3.69%
ATHA 7.76%
ATHE 0.08%
ATHX -33.50%
ATNF 2.18%
ATOS 5.37%
ATRA -5.91%
ATXI 1.09%
ATXS -0.55%
AUPH -1.08%
AURA 4.55%
AUTL -3.16%
AVBP -0.80%
AVEO 0.00%
AVIR -1.60%
AVRO -1.41%
AVTE -0.69%
AVTX -4.26%
AVXL -5.68%
AXLA 0.00%
AXSM -1.38%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 1.07%
BCAB -7.17%
BCDA -0.85%
BCDAW -46.41%
BCEL 0.00%
BCLI 3.09%
BCRX 1.73%
BCTX 13.26%
BCTXW 13.02%
BCYC 0.90%
BDRX -5.56%
BDTX 0.11%
BEAM 2.35%
BFRA -2.91%
BGNE -3.11%
BIOR -3.84%
BIVI 2.12%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -2.60%
BLTE -1.25%
BLU 0.03%
BLUE -5.14%
BMEA -15.07%
BMRN 0.18%
BNOX 4.46%
BNTC -3.06%
BNTX -2.05%
BOLD -11.74%
BOLT -0.19%
BPMC -2.18%
BPTH -4.05%
BPTS -13.47%
BRNS -0.37%
BRTX -5.66%
BTAI 13.45%
BTTX 20.00%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 1.70%
CABA 1.04%
CADL 0.80%
CALA 0.00%
CALC -8.28%
CALT -1.59%
CAPR 0.00%
CARA -12.11%
CARM 6.43%
CASI -1.18%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS 0.22%
CCCC -1.91%
CCXI 0.00%
CDAK 0.00%
CDIO -2.99%
CDIOW 24.00%
CDMO -1.76%
CDMOP 0.04%
CDT -4.88%
CDTTW -39.60%
CDTX -6.28%
CDXC 9.63%
CDXS 9.14%
CELC -3.49%
CELU 0.74%
CELUW 11.80%
CERC -1.68%
CERE -1.45%
CERO -5.03%
CEROW -10.18%
CFRX -27.95%
CGEM -0.30%
CGEN -3.32%
CGON -2.86%
CGTX -3.43%
CHMA -6.00%
CHRS 4.76%
CINC 0.00%
CING 0.34%
CINGW 34.95%
CKPT -0.48%
CLBS -16.75%
CLDX -0.75%
CLGN -0.40%
CLLS -3.11%
CLNN -1.39%
CLNNW 0.00%
CLRB 5.93%
CLSD -3.34%
CLSN -0.68%
CLVS 0.00%
CMMB -2.94%
CMND 3.23%
CMPI 0.00%
CMPX 0.94%
CMRA 0.00%
CMRAW 33.33%
CMRX -4.55%
CNCE 0.00%
CNSP -33.34%
CNST 0.00%
CNTA 0.45%
CNTB -1.50%
CNTX -6.82%
COCP -1.83%
COEPW 32.45%
COGT -2.59%
CORT 3.29%
COYA -1.45%
CPRX -1.52%
CRBP -1.56%
CRBU -7.95%
CRDF 1.99%
CRGX -1.28%
CRIS -2.64%
CRNX -6.07%
CRSP 1.12%
CRTX 2.63%
CRVO -4.50%
CRVS 1.12%
CSBR -0.19%
CTCX 1.20%
CTIC 0.06%
CTMX -4.12%
CTNM 3.72%
CTXR -4.37%
CUE -2.77%
CVAC -4.80%
CVKD -2.34%
CWBR 2.80%
CYAD -12.96%
CYCC 21.52%
CYCCP 5.28%
CYCN 7.81%
CYT -2.27%
CYTK -2.80%
CYTO 0.00%
DARE 0.86%
DAWN -0.15%
DBTX -0.81%
DBVT 4.17%
DFFN 10.28%
DICE 0.06%
DMAC 30.08%
DNLI -2.10%
DNTH -2.68%
DOMH 1.06%
DRMA -2.57%
DRMAW -1.25%
DRNA 0.00%
DRTS 0.46%
DRTSW 0.00%
DRUG -0.10%
DSGN -2.72%
DTIL -0.21%
DYAI 9.68%
EARS -1.77%
EDIT -3.12%
EDSA 4.14%
EFTR 1.50%
EFTRW -51.85%
EIGR -9.21%
ELAB -3.01%
ELDN 7.17%
ELEV -2.49%
ELOX 10.77%
ELTX -3.38%
ELVN -1.16%
ELYM 4.74%
ENGN 0.49%
ENGNW -21.67%
ENLV -1.45%
ENOB 1.79%
ENSC 6.55%
ENTA -1.31%
ENTO -4.97%
ENTX 0.53%
ENVB -0.02%
EPIX -2.68%
EPRX -2.89%
EPZM 0.00%
EQ -1.24%
EQRX -2.09%
EQRXW 0.00%
ERAS 6.01%
ERNA -2.78%
ERYP 1.30%
ESLA 4.30%
ESLAW 16.64%
ETNB -5.98%
ETON 2.59%
ETTX 0.00%
EVAX 0.00%
EVGN 2.78%
EVLO 0.00%
EWTX 0.17%
EXAI -0.57%
EXEL 0.74%
EYEG -0.69%
EYEN 0.00%
EYPT 0.00%
FATE -12.23%
FBIO 0.59%
FBIOP 0.87%
FBLG -10.70%
FBRX -0.04%
FDMT -4.77%
FENC -2.43%
FGEN -9.87%
FHTX 7.82%
FIXX 0.77%
FMTX 0.00%
FNCH 0.00%
FOLD -1.77%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE 0.58%
FULC 2.59%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -1.35%
GANX -0.85%
GBIO -1.06%
GBT 0.01%
GDTC 0.50%
GERN -1.44%
GHRS -4.27%
GLMD -3.02%
GLPG -1.79%
GLSI 9.23%
GLTO -3.90%
GLUE -2.51%
GLYC -15.02%
GMAB -0.37%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -2.34%
GNLX -4.44%
GNPX -4.41%
GNTA 3.94%
GOSS -8.11%
GOVX -4.97%
GOVXW 10.89%
GPCR -6.95%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -2.14%
GRTX -1.66%
GTHX 2.95%
GUTS -0.23%
GXGXW 41.67%
GYRE -6.30%
HALO -1.10%
HARP 0.09%
HCWB -10.05%
HEPA -3.50%
HGEN -84.62%
HILS 5.66%
HLVX -0.99%
HOOK 2.03%
HOTH -0.82%
HOWL 0.21%
HRMY 2.73%
HRTX 8.03%
HSTO 0.00%
HUMA 1.42%
HUMAW -6.25%
IBRX -6.81%
ICCC -2.10%
ICPT 0.21%
ICU 19.34%
ICUCW 4.86%
ICVX -0.91%
IDRA -23.04%
IDYA -3.41%
IFRX -3.12%
IGMS -2.05%
IKNA -0.89%
IKT 0.00%
IMAB -0.58%
IMCR -3.50%
IMGN 0.02%
IMGO 0.00%
IMMP 5.51%
IMMX -6.03%
IMNM 3.73%
IMNN 1.77%
IMPL -27.27%
IMRA 15.96%
IMRN -0.40%
IMRX -4.17%
IMTX -1.33%
IMTXW 6.00%
IMUX -3.70%
IMV 0.00%
IMVT -3.99%
INAB -1.68%
INBX -3.11%
INCY -2.06%
INDP 6.88%
INFI -52.38%
INKT 0.00%
INM 3.06%
INMB 1.95%
INO 2.02%
INSM -0.94%
INTS -3.73%
INVA 0.74%
INZY 1.26%
IOBT -7.09%
IONS 1.53%
IOVA -4.08%
IPA 0.03%
IPHA 2.54%
IPSC -2.34%
IRON -2.18%
ISEE 0.38%
ITOS 2.60%
ITRM 1.51%
IVA 6.96%
IVVD 0.00%
JAGX 0.52%
JANX -5.40%
JAZZ -0.95%
JNCE 0.00%
JSPR -2.11%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -2.47%
KALV -2.34%
KDNY 0.22%
KMPH -0.34%
KNSA -2.53%
KNTE -0.38%
KOD -8.88%
KPRX -5.76%
KPTI -8.85%
KRBP -10.00%
KRON 1.61%
KROS -0.53%
KRRO -1.59%
KRTX 0.03%
KRYS 1.00%
KTRA 9.85%
KTTA -0.65%
KTTAW 0.92%
KURA 0.66%
KYMR -3.50%
KYTX -5.56%
KZIA 7.51%
KZR -1.77%
LABP 0.57%
LBPH 0.05%
LBPS 0.00%
LBPSW 14.81%
LEGN 3.36%
LENZ -2.94%
LEXX 0.58%
LEXXW -14.63%
LGND -0.82%
LGNDV 0.00%
LGVN -8.78%
LIAN -8.28%
LIFE 2.70%
LIPO -5.29%
LIXT -9.76%
LIXTW 46.21%
LJPC -0.32%
LMNL 0.12%
LOGC 0.35%
LPCN -4.36%
LPTX -2.20%
LQDA 0.24%
LRMR -1.14%
LSTA -1.68%
LTRN 5.49%
LUMO 0.67%
LVTX -4.85%
LXEO -13.40%
LXRX -0.88%
LYEL -36.27%
LYRA 4.30%
MACK 0.10%
MBIO -11.14%
MBRX -1.43%
MCRB 1.64%
MDGL -1.90%
MDNA -13.16%
MDWD 3.18%
MDXG -1.77%
MEIP 0.70%
MESO -1.48%
MGNX -5.36%
MGTA -7.74%
MGTX -1.19%
MGX -0.54%
MIRM -0.57%
MIRO 0.59%
MIST 2.62%
MITO 0.00%
MLEC -6.54%
MLECW 2.31%
MLND -5.36%
MLTX 0.98%
MLYS -7.81%
MNKD -0.76%
MNMD 2.40%
MNOV 1.41%
MNPR -8.52%
MOLN 0.76%
MOR 0.62%
MORF -3.07%
MREO 0.14%
MRKR -0.43%
MRNA -10.61%
MRNS -6.25%
MRSN -4.52%
MRTX -0.17%
MRUS 0.92%
MRVI 0.51%
MTCR -1.29%
MTEM 7.43%
MTP -18.50%
MURA -4.02%
MYMD 1.08%
NAMS -0.10%
NAMSW 0.64%
NAUT 0.23%
NBRV 0.71%
NBSE -1.56%
NBTX 8.91%
NCNA -0.18%
NERV -1.58%
NEXI -0.74%
NGM -1.28%
NGNE 3.73%
NKGN 10.92%
NKGNW -20.00%
NKTR 1.40%
NKTX -2.77%
NLSP 2.88%
NLSPW 26.67%
NMRA -1.31%
NMTR -42.97%
NOVN -24.84%
NRBO 13.06%
NRIX -1.83%
NRSN 0.78%
NRSNW 0.00%
NRXP -8.92%
NRXPW 18.33%
NRXS -1.20%
NTBL 2.63%
NTEC -12.45%
NTHI 0.00%
NTLA -4.73%
NTRBW -31.07%
NUVL -2.11%
NVAX -5.71%
NVCT -8.44%
NVIV -34.28%
NXTC -5.88%
NYMX -0.05%
OABI 2.89%
OABIW -10.06%
OBIO 0.44%
OBSV 0.00%
OCEA -4.23%
OCGN 6.75%
OCS -1.00%
OCUL 0.23%
OCUP 0.00%
ODT -4.27%
OKYO 1.72%
OLMA -4.77%
OMER -2.31%
OMGA -2.08%
ONCO 6.37%
ONCR -3.08%
ONCS 31.87%
ONCT -2.04%
ONCY 1.97%
ONTX -0.47%
ONVO 3.72%
OPNT 0.00%
OPT -5.15%
ORGS -0.69%
ORIC -2.82%
ORMP 16.33%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -0.42%
OVID 0.01%
OYST 0.00%
PALI -0.48%
PASG 0.00%
PBLA -7.50%
PBM -3.44%
PBYI 4.56%
PCSA 0.00%
PCVX 0.54%
PDSB -5.54%
PEPG 1.49%
PGEN -6.87%
PHAR 1.99%
PHAS 0.00%
PHAT 0.58%
PHIO -3.55%
PHIOW 36.47%
PHVS -6.50%
PHXM -5.20%
PIRS 0.11%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -2.75%
PLUR 10.34%
PMN -5.55%
PMVP -1.19%
PNT 0.16%
PPBT -3.19%
PRAX 5.15%
PRDS 0.93%
PRLD -3.43%
PROG -3.47%
PROK 1.57%
PRQR 1.20%
PRTA -3.42%
PRTC 0.49%
PRTG 1.40%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -12.20%
PSTX -4.27%
PTCT -0.43%
PTE -0.82%
PTGX 0.43%
PTIXW -48.41%
PULM 1.56%
PXMD 4.76%
PYPD 1.71%
PYXS 4.41%
QLGN -5.56%
QNCX 2.23%
QNRX 0.87%
QSI -29.69%
QSIAW -9.44%
QTTB 4.54%
QURE -1.57%
RAIN -1.63%
RANI 4.28%
RAPT -2.27%
RARE 1.76%
RCKT -10.21%
REGN -0.18%
RENB -3.42%
REPL -2.72%
RETA 0.02%
REUN -0.89%
REVB -1.40%
REVBU 3.46%
REVBW 5.00%
RGLS -5.84%
RGNX -6.49%
RIGL -6.24%
RLAY -5.78%
RLMD 0.94%
RLYB -5.33%
RNA 2.11%
RNAC -1.62%
RNAZ -1.92%
RNXT 2.23%
ROIV -2.17%
ROIVW 4.56%
RPHM -1.99%
RPRX -0.84%
RPTX -0.88%
RUBY 2.70%
RVLP -32.05%
RVMD -0.56%
RVMDW -29.90%
RVNC 0.21%
RVPH -0.40%
RVPHW -5.28%
RXDX 0.09%
RXRX -6.33%
RYTM -6.06%
RYZB 0.02%
RZLT 2.84%
SABS -1.37%
SABSW -5.53%
SAGE -0.55%
SANA -2.31%
SAVA -3.63%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 1.29%
SCPH 11.15%
SCPS 0.00%
SEEL -3.55%
SEER 0.00%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -4.16%
SGMT -4.83%
SGTX -2.56%
SIOX 22.63%
SLDB -2.24%
SLGL 5.23%
SLN -8.46%
SLNO 0.83%
SLRX 0.40%
SLS -3.85%
SMMT -3.37%
SNDX 1.74%
SNGX 3.40%
SNPX -2.76%
SONN 0.54%
SPPI -0.49%
SPRB -1.68%
SPRC -3.29%
SPRO 0.38%
SRNE 0.00%
SRPT -1.01%
SRRA 0.00%
SRRK -1.67%
SRZN -2.45%
STAB 0.00%
STOK -6.85%
STRO -3.18%
STSA 0.00%
STTK 6.75%
SURF -0.93%
SVRA -4.08%
SWTX -0.41%
SYBX 0.00%
SYRS -2.06%
TALS -0.73%
TARA -9.05%
TARS -2.32%
TBPH 0.12%
TCBP 5.49%
TCDA 0.00%
TCON -0.70%
TCRR 0.00%
TCRT 4.48%
TCRX -2.42%
TECH -1.49%
TENX -0.32%
TERN -7.03%
TFFP -11.28%
TGTX -7.95%
THRX 0.12%
TIL -1.22%
TLC 0.00%
TLSA -4.53%
TNGX -3.35%
TNXP -9.61%
TNYA -5.61%
TPST 5.34%
TRDA -5.15%
TRVI 1.92%
TRVN 3.19%
TSHA -18.66%
TSVT -4.25%
TTNP -6.05%
TVTX 3.77%
TYRA -7.09%
UBX -2.73%
UNCY -4.00%
URGN 3.09%
UTHR -0.21%
VACC 11.36%
VALN -2.96%
VAXX 118.75%
VBIV -0.79%
VBLT -8.77%
VCEL 1.54%
VCNX 9.30%
VCYT -1.01%
VERA -4.47%
VERU 1.40%
VERV -3.82%
VIGL 1.61%
VINC 2.81%
VIR -1.30%
VIRI -5.66%
VIRX 3.85%
VKTX -1.32%
VLON -13.04%
VNDA -2.94%
VOR -5.65%
VRCA 1.85%
VRDN -3.57%
VRNA -2.13%
VRPX 3.58%
VRTX -0.09%
VSTM 4.92%
VTGN -2.40%
VTVT 1.28%
VTYX -1.68%
VXRT -0.06%
VYGR -0.51%
VYNE -5.80%
VYNT 7.78%
WINT -2.72%
WVE -8.29%
XBIO 1.03%
XBIT 5.00%
XCUR 0.23%
XENE -0.88%
XERS 4.99%
XFOR 5.21%
XLO 3.06%
XLRN 0.00%
XNCR 0.00%
XOMA -8.39%
XOMAO -0.45%
XOMAP -0.82%
XRTX -7.96%
YMAB -1.72%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.81%
ZNTL -1.07%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-03-25 Alloway Paul Buy 23 530 Common Stock
2024-03-25 Alloway Paul Sell 18 090 Restricted Stock Units
2024-03-25 Michaud Charles Jr Buy 6 448 Common Stock
2024-03-25 Michaud Charles Jr Sell 5 360 Restricted Stock Units
2024-01-01 Tzianabos Arthur Buy 19 140 Common Stock
INSIDER POWER
34.05
Last 94 transactions
Buy: 1 681 707 | Sell: 632 243
Korrelasjon (AI algo v.1.1b): Undervalued: 1 671.69% $293.39 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Homology Medicines Inc Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Homology Medicines Inc Korrelasjon - Valuta/Råvare

The country flag 0.26
( neutral )
The country flag 0.43
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.05
( neutral )

Homology Medicines Inc Økonomi

Annual 2023
Omsetning: $1.16M
Bruttogevinst: $578 000 (50.00 %)
EPS: $-351.57
FY 2023
Omsetning: $1.16M
Bruttogevinst: $578 000 (50.00 %)
EPS: $-351.57
FY 2022
Omsetning: $3.21M
Bruttogevinst: $609 000 (18.98 %)
EPS: $0.00840
FY 2021
Omsetning: $33.97M
Bruttogevinst: $0.00 (0.00 %)
EPS: $-1.901

Financial Reports:

No articles found.

Homology Medicines Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Homology Medicines Inc

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, cardiac and skeletal muscle, and eye. Its lead product candidate is HMI-102, which is in Phase 2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; HMI-202 to treat metachromatic leukodystrophy; and HMI-203 for the treatment of mucopolysaccharidosis type II, as well as HMI-104 for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.

Total Execution Time: 1.3867480754852 seconds
Number of API calls: 3
Number of DB calls: 9